CYRX opened at $18.15 on Monday. The company has a debt-to-equity ratio of 0.42, a quick ratio of 11.52 and a current ratio of 11.57. CryoPort has a 1 year low of $8.28 and a 1 year high of $18.99. The company has a market capitalization of $556.77 million, a P/E ratio of -58.55 and a beta of 0.85.
CryoPort (NASDAQ:CYRX) last released its earnings results on Thursday, May 2nd. The consumer goods maker reported ($0.08) earnings per share (EPS) for the quarter, hitting the Thomson Reuters’ consensus estimate of ($0.08). CryoPort had a negative net margin of 41.61% and a negative return on equity of 28.30%. The business had revenue of $6.65 million for the quarter, compared to analysts’ expectations of $6.56 million. During the same period last year, the company earned ($0.10) earnings per share. The company’s quarterly revenue was up 65.4% on a year-over-year basis. As a group, equities research analysts anticipate that CryoPort will post -0.29 EPS for the current year.
CryoPort Company Profile
CryoPort, Inc engages in the provision of logistics solutions to the life science industry. It also provides logistics solutions for biologic materials such as immunotherapies, stem cells, CAR-T cells, and reproductive cells for clients worldwide, including points-of-care, clinical research organizations central laboratories, biopharmaceuticals, contract manufacturing, health centers, and university researchers.
Further Reading: How Do You Calculate Return on Investment (ROI)?
Receive News & Ratings for CryoPort Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CryoPort and related companies with MarketBeat.com's FREE daily email newsletter.